IL-10 down-regulates human microglial IL-8 by inhibition of NF-κB activation

IN the present study, we tested the hypothesis that interleukin (IL)-10 down-regulates human microglial cell IL-8 release by inhibiting activation of nuclear factor kappa B (NF-kappa B). Immunohistochemical staining demonstrated that IL-10 markedly suppressed lipopolysaccharide (LPS)- and IL-1 beta-stimulated IL-8 expression. NF-kappa B involvement was suggested by the finding that pyrrolidinedithiocarbamate, a known inhibitor elf NF-kappa B activation, blocked LPS- and IL-1 beta-induced IL-8 production. Consistent with our hypothesis, IL-10 treatment of LPS- and IL-1 beta-stimulated microglia was associated with a marked decrease in NF-kappa B translocation from the cytoplasm to the nucleus. (C) 1998 Rapid Science Ltd.